진단용 X선을 이용한 방사선검사에서 차폐체 모양과 부가필터 변화에 따른 난소의 선량 분석
A Dose Analysis on the Ovary According to the Type of Shielding Material and the Change of Additional Filter in Radiography Using Diagnostic X-ray
- 대한방사선과학회(구 대한방사선기술학회)
- 방사선기술과학
- 방사선기술과학 제42권 제6호
-
2019.12429 - 434 (6 pages)
- 30
The gonads are directly affected by radiation exposure during radiography of the pelvis, abdomen, and spine. Exposure of the gonads to radiation can cause genetic mutations and can result in the occurrence of malignant tumors. In this study, we created three types of shielding material shapes for shielding of the ovaries, which are the gonads of female during radiography of the pelvis, and comparative evaluations using shadow shielding methods. The source surface distance(SSD) was 100 cm and the field size was 42 cm × 43 cm. The three types of shielding material shapes(type 1, 2 and 3) were assessed and the entrance surface dose in the ovaries were measured. The thickness of the shielding material was expanded from 0.3 mm to 2.4 mm and after five repetitions, radiation values were measured and mean values were calculated. The mean dose were 3.09 mGy for type 1, 3.54 mGy for type 2, and 3.19 mGy for type 3, indicating that the measurements were the lowest for type 1. When an additional filter of 0.2 Cu + 1 Al was used, the dose were 3.72 mGy for type 1, 5.43 mGy for type 2, and 4.05 mGy for type 3, indicating that the measurements were the lowest for type 1. The results show that, even if the shielding material is not thick, in other words, even with a thickness of 2.94 mGy for the SN 3(0.9 mm) of type 1, shielding can be achieved, with a patient dose lower than the diagnostic reference level(3.42 mGy). Additionally, among the three types of shielding material, the type 1 appeared to be the most appropriate shielding material. It is thought that the use of shielding material could reduce the risk factors for stochastic effects or critical effects of ionizing radiation during pelvic or lumbar radiography.
Ⅰ. 서 론
Ⅱ. 대상 및 방법
Ⅲ. 결 과
Ⅳ. 고 찰
Ⅴ. 결 론
(0)
(0)